PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

Detalles Bibliográficos
Autores principales: Wang, C., Liu, J., Lei, H., Li, Y., Wu, J., Guo, B., Hu, R., Liu, T., Ding, Y., Hu, C., Liang, S., Xiao, C., Liang, X., Huang, D., Yang, T., Zhang, W., Yang, Z., Li, J., Nan, Y., Li, Q., Xiang, Y., Wu, Y., Liu, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431588/
http://dx.doi.org/10.1097/01.HS9.0000851400.39996.c1
_version_ 1784780096199983104
author Wang, C.
Liu, J.
Lei, H.
Li, Y.
Wu, J.
Guo, B.
Hu, R.
Liu, T.
Wu, J.
Ding, Y.
Hu, C.
Liang, S.
Xiao, C.
Liang, X.
Huang, D.
Yang, T.
Zhang, W.
Yang, Z.
Li, J.
Nan, Y.
Li, Q.
Xiang, Y.
Wu, Y.
Liu, Y.
author_facet Wang, C.
Liu, J.
Lei, H.
Li, Y.
Wu, J.
Guo, B.
Hu, R.
Liu, T.
Wu, J.
Ding, Y.
Hu, C.
Liang, S.
Xiao, C.
Liang, X.
Huang, D.
Yang, T.
Zhang, W.
Yang, Z.
Li, J.
Nan, Y.
Li, Q.
Xiang, Y.
Wu, Y.
Liu, Y.
author_sort Wang, C.
collection PubMed
description
format Online
Article
Text
id pubmed-9431588
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94315882022-08-31 PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY Wang, C. Liu, J. Lei, H. Li, Y. Wu, J. Guo, B. Hu, R. Liu, T. Wu, J. Ding, Y. Hu, C. Liang, S. Xiao, C. Liang, X. Huang, D. Yang, T. Zhang, W. Yang, Z. Li, J. Nan, Y. Li, Q. Xiang, Y. Wu, Y. Liu, Y. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431588/ http://dx.doi.org/10.1097/01.HS9.0000851400.39996.c1 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Wang, C.
Liu, J.
Lei, H.
Li, Y.
Wu, J.
Guo, B.
Hu, R.
Liu, T.
Wu, J.
Ding, Y.
Hu, C.
Liang, S.
Xiao, C.
Liang, X.
Huang, D.
Yang, T.
Zhang, W.
Yang, Z.
Li, J.
Nan, Y.
Li, Q.
Xiang, Y.
Wu, Y.
Liu, Y.
PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
title PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
title_full PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
title_fullStr PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
title_full_unstemmed PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
title_short PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
title_sort pb2142: clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated lymphoma administered highly active antiretroviral therapy
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431588/
http://dx.doi.org/10.1097/01.HS9.0000851400.39996.c1
work_keys_str_mv AT wangc pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT liuj pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT leih pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT liy pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT wuj pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT guob pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT hur pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT liut pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT wuj pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT dingy pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT huc pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT liangs pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT xiaoc pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT liangx pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT huangd pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT yangt pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT zhangw pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT yangz pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT lij pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT nany pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT liq pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT xiangy pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT wuy pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy
AT liuy pb2142clinicalcharacteristicsandoutcomesofnewlydiagnosedpatientswithhumanimmunodeficiencyvirusassociatedlymphomaadministeredhighlyactiveantiretroviraltherapy

Ejemplares similares